Adamis pharmaceuticals corporation reports earnings results for the third quarter ended september 30, 2019

Adamis pharmaceuticals corporation announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced sales was usd 5.902 million compared to usd 3.832 million a year ago. operating loss was usd 7.008 million compared to usd 8.910 million a year ago. net loss was usd 6.999 million compared to usd 8.875 million a year ago. basic loss per share from continuing operations was usd 0.12 compared to usd 0.21 a year ago. for the nine months, sales was usd 16.573 million compared to usd 10.932 million a year ago. operating loss was usd 23.692 million compared to usd 26.189 million a year ago. net loss was usd 23.622 million compared to usd 26.196 million a year ago. basic loss per share from continuing operations was usd 0.47 compared to usd 0.72 a year ago.
ADMP Ratings Summary
ADMP Quant Ranking